Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	13.26B -12.6%
Revenue (ttm)	663.57M +26.2%
Net Income	202.44M +18.7%
EPS	1.47 +17.0%
Shares Out	137.75M
PE Ratio	65.56
Forward PE	n/a
Dividend	0.80 (0.79%)
Ex-Dividend Date	May 29, 2025

Volume	984,137
Average Volume	686,293
Open	101.48
Previous Close	101.49
Day's Range	96.00 - 102.36
52-Week Range	92.57 - 132.94
Beta	0.19
RSI	44.59
Earnings Date	Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.